Aspen Aerogels Inc Stock News

Aspen Aerogels Inc (NYSE: ASPN) shares are trading higher Thursday after the company announced it decided not to proceed with the concurrent public offerings of its common stock and its green conver

News that the advanced materials company will not issue additional stock as had been planned has its share price sharply higher. The post Why Is Aspen Aerogels (ASPN) Stock Up 20% Today?

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 149.3% to $1.56 in pre-market trading after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase

The company reported strong order growth from two heavyweight automakers.

Aspen Aerogels Inc (NYSE: ASPN) stated that the increased visibility to expected order volume for 2022 from General Motors Co (NYSE: GM) and Toyota Motors Corp (NYSE: TM) is driving an updated o

Aspen Aerogels, Inc. (NYSE:ASPN ) Q1 2022 Earnings Conference Call April 28, 2022 10:00 AM ET Company Participants Don Young - President & CEO Ricardo Rodriguez - CFO Keith Schilling - SVP, Technology

Koch Strategic Platforms, a subsidiary of the renowned Koch Investments Group, invested $225 million in Aspen Aerogels over the past nine months. After rallying 200% following the first Koch investmen

NORTHBOROUGH, Mass. , April 11, 2022 /PRNewswire/ -- Aspen Aerogels, Inc. (the "Company") (NYSE: ASPN) today announced that Don Young, Chief Executive Officer, and Ricardo Rodriguez, Chief Financial O

NORTHBOROUGH, Mass., Feb. 28, 2022 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen", the "Company"), a technology leader in sustainability solutions, today announced that the Company is sche

H.C. Wainwright analyst Amit Dayal lowered the price target on Aspen Aerogels Inc (NYSE: ASPN ) to $45 (an upside of 57.6%) from $65 and maintained a Buy rating on the shares. The analyst cites the company''s updated outlook stemming from plans for its thermal runaway expansion for the target drop. Though Aspen''s mid-term expectation of hitting $720 million in revenues by 2025 exceeded Dayal''s projection of roughly $460 million, the longer-term revenue outlook of potentially touching $1.6 billion was lower than his expectations of $1.9 billion. Piper Sandler analyst Alexander Potter lowered the price target on Aspen to $68 (an upside of … Full story available on Benzinga.com

Gainers: Matson (MATX) +10%. Aspen Aerogels (ASPN) +9%. Encore Wire (WIRE) +6%. Cross Country Healthcare (CCRN) +5%.

H.C. Wainwright analyst Amit Dayal lowered the price target on Aspen Aerogels Inc (NYSE: ASPN) to $45 (an upside of 57.6%) from $65 and maintained a Buy rating on the shares.  The analyst cites

Aspen Aerogels Inc. ( ASPN , Financial), a sustainability-focused aerogels engineering and manufacturing company, recently reported earnings results for its fourth quarter and full-year 2021. For the